Humoral and cellular response to the COVID-19 vaccine in immunocompromised children.
Morgans HA, Bradley T, Flebbe-Rehwaldt L, Selvarangan R, Bagherian A, Barnes AP, Bass J, Cooper AM, Fischer R, Kleiboeker S, Lee BR, LeMaster C, Markus K, Morrison S, Myers A, Myers D, Payne E, Schuster JE, Standley S, Wieser A, Warady B.
Morgans HA, et al.
Pediatr Res. 2023 Jul;94(1):200-205. doi: 10.1038/s41390-022-02374-4. Epub 2022 Nov 14.
Pediatr Res. 2023.
PMID: 36376507
Free PMC article.
The majority (86.5%) had a detectable humoral response after the 2nd and 3rd vaccine doses, with a significant increase in antibody levels after the 3rd dose. Positive T-cell responses increased from being present in 86.5% to 100% of the cohort after the 3rd dose. ...This …
The majority (86.5%) had a detectable humoral response after the 2nd and 3rd vaccine doses, with a significant increase in antibody levels a …